ADAP
Geode Capital Management’s Adaptimmune Therapeutics ADAP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $16.1K | Sell |
67,032
-42,034
| -39% | -$10.1K | ﹤0.01% | 4387 |
|
|
2025
Q1 | $21.5K | Sell |
109,066
-30,735
| -22% | -$6.06K | ﹤0.01% | 4333 |
|
|
2024
Q4 | $75.3K | Hold |
139,801
| – | – | ﹤0.01% | 4167 |
|
|
2024
Q3 | $133K | Buy |
139,801
+21,892
| +19% | +$20.8K | ﹤0.01% | 4030 |
|
|
2024
Q2 | $115K | Hold |
117,909
| – | – | ﹤0.01% | 4096 |
|
|
2024
Q1 | $186K | Hold |
117,909
| – | – | ﹤0.01% | 3963 |
|
|
2023
Q4 | $93.5K | Hold |
117,909
| – | – | ﹤0.01% | 4206 |
|
|
2023
Q3 | $92K | Hold |
117,909
| – | – | ﹤0.01% | 4274 |
|
|
2023
Q2 | $109K | Buy |
117,909
+11,999
| +11% | +$11.1K | ﹤0.01% | 4304 |
|
|
2023
Q1 | $115K | Hold |
105,910
| – | – | ﹤0.01% | 4293 |
|
|
2022
Q4 | $154K | Buy |
105,910
+33,141
| +46% | +$48.2K | ﹤0.01% | 4220 |
|
|
2022
Q3 | $78K | Hold |
72,769
| – | – | ﹤0.01% | 4655 |
|
|
2022
Q2 | $123K | Hold |
72,769
| – | – | ﹤0.01% | 4501 |
|
|
2022
Q1 | $149K | Hold |
72,769
| – | – | ﹤0.01% | 4510 |
|
|
2021
Q4 | $272K | Hold |
72,769
| – | – | ﹤0.01% | 4342 |
|
|
2021
Q3 | $376K | Hold |
72,769
| – | – | ﹤0.01% | 4163 |
|
|
2021
Q2 | $309K | Hold |
72,769
| – | – | ﹤0.01% | 4150 |
|
|
2021
Q1 | $386K | Buy |
72,769
+23,581
| +48% | +$125K | ﹤0.01% | 3893 |
|
|
2020
Q4 | $265K | Sell |
49,188
-61,467
| -56% | -$331K | ﹤0.01% | 3802 |
|
|
2020
Q3 | $883K | Buy |
110,655
+49,703
| +82% | +$397K | ﹤0.01% | 3258 |
|
|
2020
Q2 | $610K | Buy |
60,952
+9,563
| +19% | +$95.7K | ﹤0.01% | 3301 |
|
|
2020
Q1 | $139K | Sell |
51,389
-46,618
| -48% | -$126K | ﹤0.01% | 3656 |
|
|
2019
Q4 | $117K | Buy |
98,007
+34,007
| +53% | +$40.6K | ﹤0.01% | 3947 |
|
|
2019
Q3 | $96K | Hold |
64,000
| – | – | ﹤0.01% | 3952 |
|
|
2019
Q2 | $257K | Hold |
64,000
| – | – | ﹤0.01% | 3713 |
|
|
2019
Q1 | $275K | Buy |
64,000
+24,752
| +63% | +$106K | ﹤0.01% | 3642 |
|
|
2018
Q4 | $225K | Sell |
39,248
-407
| -1% | -$2.33K | ﹤0.01% | 3640 |
|
|
2018
Q3 | $537K | Sell |
39,655
-1,482
| -4% | -$20.1K | ﹤0.01% | 3438 |
|
|
2018
Q2 | $487K | Sell |
41,137
-2,074
| -5% | -$24.6K | ﹤0.01% | 3451 |
|
|
2018
Q1 | $485K | Buy |
43,211
+14,544
| +51% | +$163K | ﹤0.01% | 3406 |
|
|
2017
Q4 | $191K | Buy |
28,667
+62
| +0.2% | +$413 | ﹤0.01% | 3690 |
|
|
2017
Q3 | $234K | Hold |
28,605
| – | – | ﹤0.01% | 3620 |
|
|
2017
Q2 | $128K | Buy |
28,605
+11,764
| +70% | +$52.6K | ﹤0.01% | 3787 |
|
|
2017
Q1 | $92K | Buy |
16,841
+420
| +3% | +$2.29K | ﹤0.01% | 3841 |
|
|
2016
Q4 | $66K | Buy |
16,421
+280
| +2% | +$1.13K | ﹤0.01% | 3870 |
|
|
2016
Q3 | $113K | Buy |
16,141
+5,868
| +57% | +$41.1K | ﹤0.01% | 3778 |
|
|
2016
Q2 | $83K | Buy |
+10,273
| New | +$83K | ﹤0.01% | 3839 |
|